原发性肺癌支气管动脉介入治疗的临床应用

APPLICATION OF INTERVENTIONAL BRONCHIAL ARTERIAL THERAPY FOR PRIMARY PULMONARY CARCINOMA

目的探讨支气管动脉介入治疗原发性肺癌的疗效。方法选择原发性肺癌病人80例,行支气管动脉单纯性化疗灌注64例,化疗灌注加栓塞16例,共治疗140例次。结果症状明显改善、肿瘤缩小58例,症状减轻14例,无改善8例。结论支气管动脉介入治疗原发性肺癌疗效较好,病人痛苦小,并发症少,能明显延长病人寿命,改善病人生活质量。

Objective To explore the efficacy of interventional bronchial arterial therapy for primary pulmonary carcinoma. Methods The study was done in 80 patients, in which, 64 received single bronchial arterial chemotherapy, and 16 had em bolization plus chemotherapeutics perfusion. A total of 140 times of treatment were conducted. Results Significant relief of symptoms and tumor shrinking were observed in 58 patients; slight relief in 14 and no response in eight. Conclusion Interventional bronchial arterial chemotherapy is effective for primary pulmonary carcinoma, with less pain and complications. It could significantly prolong survival and improve their quality of life.